scholarly journals Cost per responder analysis of guselkumab versus targeted therapies in the treatment of moderate to severe plaque psoriasis in Germany

2020 ◽  
pp. 1-7
Author(s):  
Matthias Augustin ◽  
Daniel Wirth ◽  
Jörg Mahlich ◽  
Alicia N. Pepper ◽  
Cheryl Druchok
Keyword(s):  
Plaque Psoriasis ◽  
Targeted Therapies ◽  
Severe Plaque Psoriasis ◽  
Responder Analysis ◽  
Cost Per Responder

Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis

2011 ◽  
Vol 22 (3) ◽  
pp. 138-143 ◽  
Author(s):  
Silas Martin ◽  
Steven R. Feldman ◽  
Matthias Augustin ◽  
Philippe Szapary ◽  
Brad Schenkel
Keyword(s):  
Plaque Psoriasis ◽  
Severe Plaque Psoriasis ◽  
Responder Analysis ◽  
Cost Per Responder
Sign in / Sign up

Export Citation Format

Share Document